Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franciska de Beer

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Chemical Biology & Drug Design|December 14, 2019
Monoamine oxidase inhibition by selected dye compoundsFranciska de Beer, Jacobus P Petzer, Anél Petzer
JAMA Psychiatry|January 28, 2026
Interpretation of the HAMLETT Study-ReplyIris E Sommer, Shiral S Gangadin, Franciska de Beer
Schizophrenia Bulletin|June 14, 2026
Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode PsychosisShiral S Gangadin, Franciska de Beer, Iris E Sommer
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Antipsychotic medication after a first episode of psychosis: taper or continue?]Lieuwe de Haan, Shiral S Gangadin, Franciska de Beer, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 28, 2026
Citalopram serum concentrations in men and women of pre- and post-menopausal ageEline L Bosch, Franciska de Beer, Danielle C Cath, et al.
Schizophrenia Bulletin|March 21, 2026
The Impact of Sex and Age on Antipsychotic Serum ConcentrationsFranciska de Beer, Bodyl A Brand, Ben Wijnen, et al.
Psychological Medicine|November 12, 2021
Antipsychotic medication for women with schizophrenia spectrum disordersBodyl A Brand, Yudith R A Haveman, Franciska de Beer, et al.
Psychological Medicine|May 10, 2023
Antipsychotic medication for women with schizophrenia spectrum disorders - CORRIGENDUMBodyl A Brand, Yudith R A Haveman, Franciska de Beer, et al.
Schizophrenia Bulletin|October 28, 2025
Trajectories of Clozapine Concentrations in Women Across Menopausal AgeFranciska de Beer, Iris M H Hamers, Michalina Prycka, et al.
Scientific Reports|October 2, 2024
Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patientsFranciska de Beer, Sanne Koops, Robert A Schoevers, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Chemical Biology & Drug Design|December 14, 2019
Monoamine oxidase inhibition by selected dye compoundsFranciska de Beer, Jacobus P Petzer, Anél Petzer
JAMA Psychiatry|January 28, 2026
Interpretation of the HAMLETT Study-ReplyIris E Sommer, Shiral S Gangadin, Franciska de Beer
Schizophrenia Bulletin|June 14, 2026
Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode PsychosisShiral S Gangadin, Franciska de Beer, Iris E Sommer
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Antipsychotic medication after a first episode of psychosis: taper or continue?]Lieuwe de Haan, Shiral S Gangadin, Franciska de Beer, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 28, 2026
Citalopram serum concentrations in men and women of pre- and post-menopausal ageEline L Bosch, Franciska de Beer, Danielle C Cath, et al.
Schizophrenia Bulletin|March 21, 2026
The Impact of Sex and Age on Antipsychotic Serum ConcentrationsFranciska de Beer, Bodyl A Brand, Ben Wijnen, et al.
Psychological Medicine|November 12, 2021
Antipsychotic medication for women with schizophrenia spectrum disordersBodyl A Brand, Yudith R A Haveman, Franciska de Beer, et al.
Psychological Medicine|May 10, 2023
Antipsychotic medication for women with schizophrenia spectrum disorders - CORRIGENDUMBodyl A Brand, Yudith R A Haveman, Franciska de Beer, et al.
Schizophrenia Bulletin|October 28, 2025
Trajectories of Clozapine Concentrations in Women Across Menopausal AgeFranciska de Beer, Iris M H Hamers, Michalina Prycka, et al.
Scientific Reports|October 2, 2024
Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patientsFranciska de Beer, Sanne Koops, Robert A Schoevers, et al.
Pageof 2